Geetha Shanmugam[Author] - Search Results

Year	Number of Results
2004	1
2013	1
2016	1
2019	1
2021	3
2022	9
2023	10
2024	4

1

Neem Leaf Glycoprotein in immunoregulation of cancer.

Singh A, Chatterjee A, Rakshit S, Shanmugam G, Mohanty LM, Sarkar K. Singh A, et al. Among authors: shanmugam g. Hum Immunol. 2022 Nov;83(11):768-777. doi: 10.1016/j.humimm.2022.08.012. Epub 2022 Aug 31. Hum Immunol. 2022. PMID: 36055899 Review.

2

Coronary artery disease and cancer: a significant resemblance.

Rakshit S, Shanmugam G, Sarkar K. Rakshit S, et al. Among authors: shanmugam g. Med Oncol. 2022 Sep 7;39(12):187. doi: 10.1007/s12032-022-01789-7. Med Oncol. 2022. PMID: 36071253 Review.

3

Role of chemotherapeutic drugs in immunomodulation of cancer.

Mukherjee O, Rakshit S, Shanmugam G, Sarkar K. Mukherjee O, et al. Among authors: shanmugam g. Curr Res Immunol. 2023 Aug 31;4:100068. doi: 10.1016/j.crimmu.2023.100068. eCollection 2023. Curr Res Immunol. 2023. PMID: 37692091 Free PMC article. Review.

4

HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases.

Shanmugam G, Rakshit S, Sarkar K. Shanmugam G, et al. Transl Oncol. 2022 Feb;16:101312. doi: 10.1016/j.tranon.2021.101312. Epub 2021 Dec 16. Transl Oncol. 2022. PMID: 34922087 Free PMC article. Review.

5

Clinical relevance and therapeutic aspects of professional antigen-presenting cells in lung cancer.

Shanmugam G, Das S, Paul S, Rakshit S, Sarkar K. Shanmugam G, et al. Med Oncol. 2022 Sep 29;39(12):237. doi: 10.1007/s12032-022-01841-6. Med Oncol. 2022. PMID: 36175603 Review.

6

Involvement of CCCTC-binding factor in epigenetic regulation of cancer.

Bose S, Saha S, Goswami H, Shanmugam G, Sarkar K. Bose S, et al. Among authors: shanmugam g. Mol Biol Rep. 2023 Dec;50(12):10383-10398. doi: 10.1007/s11033-023-08879-3. Epub 2023 Oct 15. Mol Biol Rep. 2023. PMID: 37840067 Review.

7

DNA methylation and cancer: transcriptional regulation, prognostic, and therapeutic perspective.

Bhootra S, Jill N, Shanmugam G, Rakshit S, Sarkar K. Bhootra S, et al. Among authors: shanmugam g. Med Oncol. 2023 Jan 5;40(2):71. doi: 10.1007/s12032-022-01943-1. Med Oncol. 2023. PMID: 36602616 Review.

8

XPG in the Nucleotide Excision Repair and Beyond: a study on the different functional aspects of XPG and its associated diseases.

Pal R, Paul N, Bhattacharya D, Rakshit S, Shanmugam G, Sarkar K. Pal R, et al. Among authors: shanmugam g. Mol Biol Rep. 2022 Aug;49(8):7995-8006. doi: 10.1007/s11033-022-07324-1. Epub 2022 May 20. Mol Biol Rep. 2022. PMID: 35596054 Review.

9

ECMO for TACO Secondary to Massive Post-Cesarean Section Hemorrhage.

Tafesse H, Shanmugam G, Long B, BuAbbud A, Aziz S, Parr KG. Tafesse H, et al. Among authors: shanmugam g. J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt A):2578-2582. doi: 10.1053/j.jvca.2021.09.007. Epub 2021 Sep 11. J Cardiothorac Vasc Anesth. 2022. PMID: 34629239 No abstract available.

10

Diospyros malabarica fruit preparation mediates immunotherapeutic modulation and epigenetic regulation to evoke protection against non-small cell lung cancer (NSCLC).

Bhootra S, Jill N, Rajak R, Shanmugam G, Rakshit S, Kannanthodi S, Thakkar V, George M, Sarkar K. Bhootra S, et al. Among authors: shanmugam g. J Ethnopharmacol. 2023 Oct 5;314:116525. doi: 10.1016/j.jep.2023.116525. Epub 2023 May 5. J Ethnopharmacol. 2023. PMID: 37149067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year